NASDAQ:LXEO | Profit Breakdown | Lexeo Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$28.02M-$25.87M-$25.87M
2026-03-31-$22.33M-$20.2M-$20.2M
2025-12-31-$23.12M-$20.63M-$20.92M
2025-09-30-$21.65M-$20.28M-$20.28M
2025-06-30-$30.69M-$26.1M-$26.1M
2025-03-31-$33.81M-$32.66M-$32.66M
2024-12-31-$27.38M-$26.03M-$25.92M
2024-09-30-$31.54M-$29.49M-$29.49M
2024-06-30-$23.55M-$21.24M-$21.24M
2024-03-31-$23.29M-$21.68M-$21.68M
2023-12-31-$14.97M-$14.19M-$14.19M
2023-09-30-$20.27M-$20.11M-$20.11M
2023-06-30-$13.98M-$13.44M-$13.44M
2023-03-31-$19.29M-$18.66M-$18.66M
2022-12-31$0.00-$15.2M-$14.58M-$14.58M
2022-09-30$531,000.00-$17.48M-$17.06M-$17.06M
2022-06-30-$15.14M
2022-03-31-$12.5M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$109.26M-$99.67M-$99.96M
2024-12-31-$105.77M-$98.44M-$98.33M
2023-12-31-$68.51M-$66.39M-$66.39M
2022-12-31$654,000.00-$60.51M-$59.28M-$59.28M